The Economic Times News

Corona Remedies IPO Day 3: Demand stays strong as GMP hits 25%; should investors apply?

Corona Remedies Rs 655.37-crore IPO has seen strong demand, with overall subscription at 9.33 times by Day 2. The GMP of around Rs 270 suggests a potential listing near Rs 1,332. While the company shows robust growth, brand concentration, regional dependence, and supply-chain risks remain. Analysts, however, maintain a long-term subscribe view given its strong fundamentals and strategic positioning.